ALPS Advisors’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-9,039
Closed -$277K 1034
2022
Q4
$277K Sell
9,039
-45
-0.5% -$1.35K ﹤0.01% 928
2022
Q3
$224K Buy
+9,084
New +$300K ﹤0.01% 990
2019
Q3
Sell
-9,918
Closed -$238K 847
2019
Q2
$238K Sell
9,918
-3,177
-24% -$93.6K ﹤0.01% 869
2019
Q1
$487K Sell
13,095
-1,161
-8% -$42.2K ﹤0.01% 524
2018
Q4
$402K Buy
14,256
+231
+2% +$7.31K ﹤0.01% 601
2018
Q3
$553K Buy
14,025
+3,218
+30% +$141K ﹤0.01% 540
2018
Q2
$479K Sell
10,807
-489
-4% -$24.3K ﹤0.01% 626
2018
Q1
$550K Buy
+11,296
New +$565K ﹤0.01% 459
2017
Q4
Sell
-4,698
Closed -$238K 850
2017
Q3
$238K Sell
4,698
-634
-12% -$29.9K ﹤0.01% 746
2017
Q2
$202K Buy
+5,332
New +$210K ﹤0.01% 750

Other funds holding CC

ALPS Advisors's CC Position: Q1 2023 in Review

ALPS Advisors sold out of Chemours (CC) in Q1 2023, closing a stake of 9,039 shares — an estimated $277K sold.

ALPS Advisors first reported a position in CC in Q2 2017 and held it in 10 quarters. The position peaked at $553K in Q3 2018. 486 funds tracked by Wall St. Rank hold CC as of Q1 2023.

  • ALPS Advisors reported no remaining Chemours position as of Q1 2023 after selling out during the quarter.
  • ALPS Advisors sold 9,039 Chemours shares in Q1 2023, an estimated $277K.
  • ALPS Advisors first reported a position in Chemours in Q2 2017 and held it in 10 quarters.
  • ALPS Advisors's Chemours position peaked at $553K in Q3 2018.
  • 486 funds tracked by Wall St. Rank held Chemours as of Q1 2023.

Based on ALPS Advisors's 13F filing for Q1 2023, filed 10 May 2023.